Overview Adjuvant Treatment in Extensive Unilateral Retinoblastoma Primary Enucleated (RB SFCE 2009) Status: Recruiting Trial end date: 2029-09-01 Target enrollment: Participant gender: Summary Postoperative Treatment of Unilateral Retinoblastoma After Primary Enucleation according to histopathological risk factors of the International Retinoblastoma Staging Working Group. Phase: Phase 2 Details Lead Sponsor: Institut CurieTreatments: CarboplatinCyclophosphamideEtoposideEtoposide phosphateThiotepaVincristine